K192433

Substantially Equivalent

LZI Methadone II Enzyme Immunoassay

Applicant: Lin-Zhi International, Inc.
Product code: DJR
Advisory panel: Clinical Toxicology
Date received: 2019-09-05
Decision date: 2019-10-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Santa Clara, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.